SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-21-026749
Filing Date
2021-11-15
Accepted
2021-11-15 16:37:16
Documents
89
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q cbli20210930_10q.htm   iXBRL 10-Q 1166459
2 EXHIBIT 3.1 ex_277921.htm EX-3.1 226129
3 EXHIBIT 31.1 ex_277922.htm EX-31.1 13734
4 EXHIBIT 31.2 ex_277923.htm EX-31.2 13737
5 EXHIBIT 32.1 ex_277924.htm EX-32.1 8615
  Complete submission text file 0001437749-21-026749.txt   6969294

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA stab-20210930.xsd EX-101.SCH 78657
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE stab-20210930_cal.xml EX-101.CAL 60290
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE stab-20210930_def.xml EX-101.DEF 507282
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE stab-20210930_lab.xml EX-101.LAB 442459
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE stab-20210930_pre.xml EX-101.PRE 545990
11 EXTRACTED XBRL INSTANCE DOCUMENT cbli20210930_10q_htm.xml XML 854207
Mailing Address 2537 RESEARCH BOULEVARD, SUITE 201 FORT COLLINS CO 80526
Business Address 2537 RESEARCH BOULEVARD, SUITE 201 FORT COLLINS CO 80526 (888) 613-8802
Statera Biopharma, Inc. (Filer) CIK: 0001318641 (see all company filings)

IRS No.: 200077155 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32954 | Film No.: 211411557
SIC: 2834 Pharmaceutical Preparations